Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanobone and PRF in Ridge Splitting for Atrophic Maxilla
NCT02836678Phase 3Unknown
- Sponsor
- Cairo University
- Start
- Jan 2017
- Primary completion
- Sep 2018
01
Overview
Phase 3, randomised, open-label trial of nano-crystalline hydroxyapatite silica gel in Maxillary atrophy (2 arms), sponsored by Cairo University. Primary endpoint: Horizontal bone gain at 5 months. Status: unknown.
02
Drugs
nano-crystalline hydroxyapatite silica gel
03
Conditions
Maxillary atrophy
Beyond the preview
Go deeper on NCT02836678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02836678.